Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trial of Chinese Herbal Medicine for Idiopathic Pulmonary Fibrosis (IPF)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Either gender aged 40-75;~* Has a diagnosis of IPF, made by a respiratory expert based on International Classification of Diseases (ICD-10);~* No participation in another clinical study within 4 weeks of study start.~* Participation in this study must be voluntary and not coerced.~Exclusion Criteria:~* Have received lung transplantation.~* Any condition that may compromise patient safety.~* Pregnant women or women trying to become pregnant will be excluded from the study.~* History of drug or alcohol abuse within 6 months of study start.~* History of immunocompromise, including a positive HIV test result.~* Impaired liver and renal functions.~* Known allergies to any Chinese herbs and participants with numerous or severe allergies to any allergen.~* Pre-existing conditions including renal failure, chronic renal problems, chronic hepatitis, other pulmonary problems, diabetes, and heart problems will be excluded from the study.~* Either mentally incompetent or are unable to give informed consent because of the language barrier.~* Taking the following drugs, even as part of their current treatment regimen for IPF: pirfenidone, nintedanib, antiplatelet drugs (including aspirin, clopidogrel (Plavix), and dipyridamole (Persantine), anticoagulant drugs (including warfarin (Coumadin), enoxparin (Lovenox), and heparin), cardiac glycosides (e.g. digoxin), sedatives and sedative-containing drugs (including barbiturates, narcotic analgesics, benzodiazepines, and antihistamines), and traditional Chinese herbal medicines or granules, or other herbal medicines or supplements.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- PROLUNG (Type: EXPERIMENTAL): Herbal formula treatment PROLUNG in additional to current therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).